| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2006;48:437.)
© 2006 American Heart Association, Inc.
Original Articles |
From the Hypertension Program, University Hospital Clementino Fraga Filho, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro, Brasil.
Correspondence to Gil Salles, Rua Croton, 72, Jacarepagua, Rio de Janeiro, RJ, Brasil, CEP: 22750-240. E-mail gilsalles{at}hucff.ufrj.br
| Abstract |
|---|
|
|
|---|
Key Words: echocardiography electrocardiography hypertension, arterial hypertrophy
| Introduction |
|---|
|
|
|---|
However, the independent associations of ECG strain with LVM and other factors have not been extensively investigated.6,13 It has not been established yet whether in patients with echocardiographically demonstrated LVH the presence of ECG strain is associated with higher LVM. This knowledge is potentially important, because the presence of ECG strain may provide additional prognostic information beyond that obtained from echocardiographic LVH.
So, the aim of this study was to investigate in a large group of resistant hypertensive patients the importance of the relationships between the presence of the ECG strain pattern and other clinical, laboratory, 24-hour ambulatory blood pressure (BP) monitoring (ABPM) and electrocardiographic variables, and, specifically, to assess whether patients with ECG strain have increased LVM after controlling for other variables that could potentially impact this association.
| Methods |
|---|
|
|
|---|
140/90 mmHg using
3 antihypertensive drugs in full dosages always including a diuretic) were submitted to a standard protocol that included a thorough clinical examination, laboratory evaluation, 12-lead ECG, 24-hour ABPM, and 2D echocardiography. Compliance to anti-hypertensive treatment was evaluated in the first interview by a validated standard questionnaire.16 Only patients considered medium or highly adherent to treatment were enrolled into the study. In clinical interview, demographic and anthropometric characteristics (sex, age, race, weight, height, and waist circumference), cardiovascular risk factors (diabetes, dyslipidemia, smoking, physical inactivity, and obesity), and target-organ damage (coronary heart disease [CHD], heart failure, cerebrovascular disease, advanced retinopathy, and peripheral arterial disease) were recorded.17 In particular, CHD was diagnosed by history of angina, previous myocardial infarction or myocardial revascularization procedures, or by the presence of ECG pathological Q-waves (Minnesota codes: 1.1 and 1.2) or echocardiographic segmental wall motion abnormalities. BP was measured twice by a trained physician, with patients in the sitting position, using a calibrated mercury sphygmomanometer and a suitably sized cuff. First and fifth Korotkoffs sounds were the criteria for systolic (SBP) and diastolic BP (DBP), and BP considered was the mean between the 2 readings.17 Pulse pressure (PP) was calculated as SBP minus DBP. Laboratory evaluation included fasting glycemia, serum creatinine, and lipid profile. Microalbuminuria, proteinuria, and creatinine were evaluated in a sterile 24-hour urine collection. Abnormal microalbuminuria was considered if it was
30 and
300 mg/24 hours. ABPM was recorded using Mobil O Graph (version 12) equipment, approved by the British Society of Hypertension.18 All of the patients used their prescribed antihypertensive medications during ABPM. A reading was taken every 10 minutes throughout the day and every 20 minutes at night. Parameters evaluated were mean 24-hour, daytime, and nighttime SBP, DBP, and PP and nocturnal SDB/DBP reduction.
Standard resting 12-lead ECGs were recorded digitally in the same equipment (CardioFax V ECG, Nihon-Kohden) and response frequencies at 25 mm/s paper speed and 10 mm/mV amplitude. A single independent observer unaware of other patients data performed all of the electrocardiographic procedures. Typical ST-T wave strain pattern was defined by the presence of downsloping convex ST segment with
50 µV ST depression (Minnesota codes: 4.1 and 4.2), concomitantly with inverted asymmetrical T-wave opposite to QRS axis (Minnesota codes: 5.1 and 5.2) in leads V5 and V6. Thirty-one patients were excluded because of complete left bundle branch block or atrial fibrillation that prevented correct evaluation of the strain pattern presence. Thus, 440 RH patients compounded the study cohort for this report. Also, QRS voltages and QT interval durations were measured in each lead, as described previously.14 Sokolow-Lyon (SV1+RV5 or V6), Cornell (SV3+RaVL with 0.6 mV added in women), and Cornell voltage-duration product (Cornell voltagexmean QRS duration) were recorded, as well as maximum heart rate-corrected (by Bazetts formula) QT interval duration (QTcmax).
Good-quality comprehensive 2D transthoracic echocardiograms (Sonoline G60S, Siemens) were performed by a single experienced observer blinded to other patients data. 2D guided M-mode images were obtained from the short axis parasternal view at the level of the tips of the mitral valve leaflets, and measurements of interventricular septal wall thickness, posterior wall thickness (PWT), and LV end diastolic diameter (LVEDD) were made at the peak of the ECG R wave according to the Penn convention.19 The mean of 3 cycles was considered. LVM was calculated by the anatomically validated cube formula of Devereux and Reichek19: LVM (g) =1.04 [(interventricular septal wall thickness+PWT+LVEDD)3(LVEDD)3]14 and indexed to body surface area (LVMI) and, alternatively, to height2.7. Echocardiographic LVH was defined as LVMI >116 g/m2 in men and >104 g/m2 in women. Relative wall thickness (RWT) was measured as the ratio of 2x (PWT/LVEDD) and considered increased if >0.43. Patterns of LV geometry were defined according to LVH and RWT: (1) normal (no LVH, normal RWT); (2) concentric remodeling (no LVH, increased RWT); (3) eccentric hypertrophy (LVH, normal RWT); and (4) concentric hypertrophy (LVH, increased RWT).
Statistical Analysis
Continuous data were described as means and SDs. Bivariate comparisons between patients with and without ECG strain pattern were performed by unpaired t test in normally distributed data and by nonparametric Mann-Whitney test in asymmetrically distributed data. Categorical data were compared by
2 test. Associations with ECG strain were determined by stepwise multivariate logistic regression analysis. All of the variables with a P<0.20 in bivariate analysis entered into the multivariate analysis in a backward selection procedure. Odds ratios with their 95% CIs were calculated for each independently associated variable. For continuous variables, Odds ratios were calculated for increments of 1 SD. Finally, echocardiographic variables were further compared using ANCOVA to adjust for all of the baseline differences in clinical-demographic, laboratory, 24-hour ABPM, and electrocardiographic variables between patients with and without ECG strain. A similar analysis was also performed exclusively for the subgroup of patients with established echocardiographic LVH. All of the statistics were performed by SPSS statistical package version 13.0, and a 2-tailed P<0.05 was regarded as significant.
| Results |
|---|
|
|
|---|
|
|
Multivariate Associates With ECG Strain
Table 3 presents the results of multivariate logistic regression analysis for variables independently associated with the presence of the strain pattern on ECG. Increased LVMI was the strongest independently associated variable with strain. Other variables selected were increased 24-hour SBP, prolonged maximum QTc interval duration, lower waist circumference, male gender, physical inactivity, greater number of drugs in antihypertensive treatment, the presence of CHD and peripheral arterial disease at baseline, and increased fasting glycemia and serum creatinine.
|
Echocardiographic Findings in Relation to ECG Strain
Relationships between LV structure and the presence or absence of ECG strain pattern are presented in Table 4. Patients with strain had significantly greater LV wall thicknesses, diastolic LV internal dimension, and LVM either indexed to body surface area or to height2.7. Because strain was more strongly associated with increased LV wall thicknesses than with greater LV cavity dimension, it was also associated with increased RWT and with a greater prevalence of the concentric hypertrophy LV geometric pattern. After adjustment to all of the baseline differences between patients with and without ECG strain that could influence LV structure, by means of ANCOVA (Table 4, top), ECG strain remained strongly associated with increased LV wall thicknesses and RWT and LVM indexes but not with increased diastolic LV cavity dimension. The same finding was demonstrated in the subgroup of patients with echocardiographic LVH (Table 4, bottom).
|
| Discussion |
|---|
|
|
|---|
These findings offer insights into the known association between the ECG strain pattern and untoward cardiovascular prognosis in hypertensive patients7,8,11 and in general populations,9,10,20 suggesting that the presence of ECG strain may provide additional prognostic information beyond that derived from echocardiographic LVH and mass. Only 1 previous study20 addressed this hypothesis, showing that the degree of ST segment depression measured at the microvolt level, a possible quantitative measurement of ECG strain, added prognostic information to echocardiographic LVH for mortality, although only a few individuals actually had enough ST depression to fulfill criterion for typical ECG strain.20 Clearly, this important question shall be further addressed in future well-designed prospective studies.
Although many previous investigations15 have demonstrated associations between the presence of classical strain pattern on ECG and LVH, only 2 studies specifically evaluated the relationships between ECG strain and echocardiographic LV structure and mass,6,13 one of them13 using the quantitative measurement of ST depression as a reflection of strain. Both studies support our findings that patients with strain had significantly higher LV wall thicknesses and mass than patients without strain, even after controlling for baseline differences between them. Moreover, the present study demonstrates that in patients with already established echocardiographic LVH, the presence of typical ECG strain pattern is also independently associated with increased LV wall thicknesses and mass. As far as we know, this finding is new and potentially important for cardiovascular risk stratification. Also, patients with strain showed a greater prevalence of the concentric hypertrophy LV geometric pattern in accordance with that reported in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.6
The other independent factors associated with the presence of ECG strain pattern, higher 24-hour SBP, male gender, increased serum creatinine and fasting glycemia (or a greater prevalence of diabetes), and greater prevalences of CHD and peripheral arterial disease, have all been demonstrated in previous studies to be associated with ECG strain.3,69,12,13
Regarding 24-hour ABPM parameters, only one previous investigation7 evaluated their relationships with the presence of ECG strain. Our findings support this study, showing that patients with strain have higher ambulatory BPs (systolic, diastolic, or PP), either during daytime or nighttime, than those without ECG strain. The implications for cardiovascular prognosis are clear, because ABPM is superior to office BPs for cardiovascular risk stratification.21 Furthermore, patients with strain have a decreased nocturnal BP fall and a higher prevalence of the nondipper status, another potential adverse prognostic marker derived from ABPM.22
The association between the presence of ECG strain and QTc interval prolongation has not been explored before but is not unexpected. QTc interval prolongation has been associated with LVH14 and is a well-known marker of abnormal ventricular repolarization.23 The typical ECG strain pattern is also an abnormality of ventricular repolarization secondary to anatomic myocardial cell hypertrophy24 and to subendocardial ischemia with or without underlying CHD.3,25 Individuals with QT interval prolongation are at increased risk for theoccurrence of life-threatening ventricular arrhythmias.23 Thus, this relationship may help to explain the adverse cardiovascular outcomes of patients with strain, particularly in relation to sudden arrhythmic death.
An unexpected finding of this study was the relation between body mass and ECG strain. Patients with strain were leaner than those without strain in bivariate analysis, and a lower waist circumference remained as one of the independent factors associated with ECG strain in multivariate analysis. This association may reflect a real demographic difference between subjects with and without ECG strain in a similar manner to that reported in the LIFE study26 in relation to obesity and Sokolow-Lyon voltage criterion for LVH.
Some limitations of the present study are important to note. Its cross-sectional design prevents firm conclusions about the associations found, and no inferences about ECG strain development or regression over time can be made. Another potential flaw of this study is the fact that no provocative test to diagnose silent CHD, a factor that potentially affects the occurrence of ECG strain, was performed. So, the statistical adjustment for the presence of CHD may have been incomplete, and we cannot with certainty rule out the possibility that subclinical CHD might be residually affecting our findings.
Perspectives
This study with a large group of patients with RH provides evidence that the presence of the classic ECG strain pattern is independently associated with higher LV wall thicknesses and mass and also with other unfavorable cardiovascular risk factors, such as increased 24-hour BP, prolonged QTc interval duration, increased serum creatinine and glycemia, male gender, and atherosclerotic vascular disease. It needs to be further studied prospectively whether the presence of ECG strain confers additional cardiovascular risk stratification over and above that derived from echocardiographic LVH and mass. Moreover, it remains to be established whether multifactorial interventions are capable of regressing the ECG strain pattern and decreasing the high cardiovascular risk profile of resistant hypertensive patients with strain.
| Acknowledgments |
|---|
G.S., C.C., and K.B. have research grants from the Brazilian National Research Council, and the José Bonifácio University Foundation provided partial financial support.
Disclosures
None.
Received April 11, 2006; first decision April 27, 2006; accepted July 5, 2006.
| References |
|---|
|
|
|---|
2. Devereux RB, Reichek N. Repolarization abnormalities of left ventricular hypertrophy. Clinical, echocardiographic and hemodynamic correlates. JElectrocardiol. 1982; 14: 4754.
3. Pringle SD, Macfarlane PW, McKillop JH, Lorimer AR, Dunn FG. Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension. J Am Coll Cardiol. 1989; 13: 13771381.[Abstract]
4. Levy D, Labib SB, Andersen KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990; 81: 815820.
5. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Guerrieri M, Zampi I, Battistelli M, Bartoccini C, Porcellati C. Improved electrocardiographic diagnosis of echocardiographic left ventricular hypertrophy. Am J Cardiol. 1995; 74: 714719.
6. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Dahlöf B. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. J Am Coll Cardiol. 2001; 38: 514520.
7. Schillaci G, Pirro M, Pasqualini L, Vaudo G, Ronti T, Gemelli F, Marchesi S, Reboldi G, Porcellati C, Mannarino E. Prognostic significance of isolated, non-specific left ventricular repolarization abnormalities in hypertension. J Hypertens. 2004; 22: 407414.[Medline] [Order article via Infotrieve]
8. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Snapinn S, Dahlöf B. Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension. 2004; 44: 4854.
9. Larsen CT, Dahlin J, Blackburn H, Scharling H, Appleyard M, Sigurd B, Schnohr P. Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave. The Copenhagen city heart study. Eur Heart J. 2002; 23: 315324.
10. Hsieh BP, Pham MX, Froelicher VF. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy. Am Heart J. 2005; 150: 161167.[CrossRef][Medline] [Order article via Infotrieve]
11. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Reboldi G, Porcellati C. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol. 1998; 31: 383390.
12. Ichihara Y, Sugino M, Hattori R, Anno T, Mizuno Y, Yokoi M, Kondo T, Hirai M, Kawamura T. Relation of electrocardiographic left ventricular hypertrophy with and without T-wave changes to systemic blood pressure, body mass, and serum lipids and blood glucose levels in Japanese men. Am J Cardiol. 1997; 80: 730735.[CrossRef][Medline] [Order article via Infotrieve]
13. Okin PM, Devereux RB, Fabsitz RR, Lee ET, Galloway JM, Howard BV. Quantitative assessment of electrocardiographic strain predicts increased left ventricular mass: the Strong Heart study. J Am Coll Cardiol. 2002; 40: 13951400.
14. Salles G, Leocadio S, Bloch K, Nogueira AR, Muxfeldt E. Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension. Hypertension. 2005; 46: 12071212.
15. Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. True resistant hypertension: Is it possible to be recognized in the office? Am J Hypertens. 2005; 18: 15341540.[CrossRef][Medline] [Order article via Infotrieve]
16. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24: 6774.[Medline] [Order article via Infotrieve]
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003; 42: 12061252.
18. Jones CR, Taylor K, Chowienczyk P, Poston L, Shennan AH. A validation of the Mobil O Graph (version 12) ambulatory blood pressure monitor. Blood Press Monit. 2000; 5: 233238.[CrossRef][Medline] [Order article via Infotrieve]
19. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977; 55: 613618.
20. Okin PM, Roman MJ, Lee ET, Galloway JM, Howard BV, Devereux RB. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study. Hypertension. 2004; 43: 769774.
21. Clement DL, DeBuyzere ML, DeBacquer DA, Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Niepen PV, OBrien E. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003; 348: 24072415.
22. Verdecchia P. Prognostic value of ambulatory blood pressure. Current evidence and clinical implications. Hypertension. 2000; 35: 844851.
23. Bednar MM, Harrigan EP, Anziano RJ, Camm AJ, Ruskin JN. The QT interval. Prog Cardiovasc Dis. 2001; 43: 145.[Medline] [Order article via Infotrieve]
24. Thiry PS, Rosenberg RM, Abbott JA. A mechanism for the electrocardiogram in response to left ventricular hypertrophy and acute ischemia. Circ Res. 1975; 36: 92104.
25. Anderson HV, Stokes MJ, Leon M, Abu-Halawa SA, Stuart Y, Kirkeeide RL. Coronary artery flow velocity is related to lumen area and regional left ventricular mass. Circulation. 2000; 102: 4854.
26. Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlöf B. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients. The Life Study. Hypertension. 2000; 35: 1318.
This article has been cited by other articles:
![]() |
P. M. Okin, L. Oikarinen, M. Viitasalo, L. Toivonen, S. E. Kjeldsen, M. S. Nieminen, J. M. Edelman, B. Dahlof, R. B. Devereux, and for the LIFE Study Investigators Prognostic Value of Changes in the Electrocardiographic Strain Pattern During Antihypertensive Treatment: The Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE) Circulation, April 14, 2009; 119(14): 1883 - 1891. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Williams The Year in Hypertension J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1803 - 1817. [Full Text] [PDF] |
||||
![]() |
G. F. Salles, R. Fiszman, C. R.L. Cardoso, and E. S. Muxfeldt Relation of Left Ventricular Hypertrophy With Systemic Inflammation and Endothelial Damage in Resistant Hypertension Hypertension, October 1, 2007; 50(4): 723 - 728. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |